Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged - MSN Health & Fitness - Infectious Diseases
Links shared publicly online about this topic.
- 1,221total visits
Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged - MSN Health & Fitness - Infectious Diseases
View full resource at health.msn.com
Tags: Infectious Disease, Infection, Lyme Disease, Disease and Condition, Exercise and Fitness, Antibiotic
Most Recently Shared on April 22, 2010 at 8:52 pm By:
Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged: http://bit.ly/c5JNxe
Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged - Tom Heston
tomheston.com — “Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged - Tom Heston” View full resource at tomheston.com
Most Recently Shared on April 24, 2010 at 11:32 pm By:
Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged http://bit.ly/c2GwVb
Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged - Drugs.com MedNews
drugs.com — “After more than a year of study, a specially appointed panel at the Infectious Diseases Society of America has decided that controversial guidelines for the tre” View full resource at drugs.com
Most Recently Shared on April 23, 2010 at 12:24 am By:
Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged - http://bit.ly/bn60XZ
HealthDay
consumer.healthday.com — “HealthDay” View full resource at consumer.healthday.com
Most Recently Shared on April 22, 2010 at 11:29 pm By:
Review panel leaves controversial #Lyme Disease guidelines unchanged dismissing need for long-term #antibiotic therapy http://bit.ly/dBLexb
Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged --Doctors Lounge
doctorslounge.com — “Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on April 22, 2010 at 10:07 pm By:
DoctorsLounge: Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged: http://bit.ly/daTb2G
Advertisement

